499 related articles for article (PubMed ID: 8298798)
1. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.
Tschöpl M; Miller RC; Pelton J; Stoclet JC; Bucher B
Br J Pharmacol; 1993 Nov; 110(3):1098-104. PubMed ID: 8298798
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
Haynes JM; Hill SJ; Selbie LA
Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
[TBL] [Abstract][Full Text] [Related]
3. Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.
Gicquiaux H; Tschöpl M; Doods HN; Bucher B
Br J Pharmacol; 1996 Dec; 119(7):1313-8. PubMed ID: 8968537
[TBL] [Abstract][Full Text] [Related]
4. Effects of neuropeptide Y and agonists selective for neuropeptide Y receptor sub-types on arterioles of the guinea-pig small intestine and the rat brain.
Xia J; Neild TO; Kotecha N
Br J Pharmacol; 1992 Nov; 107(3):771-6. PubMed ID: 1472974
[TBL] [Abstract][Full Text] [Related]
5. Examination of the role of the amphipathic alpha-helix in the interaction of neuropeptide Y and active cyclic analogues with cell membrane receptors and dimyristoylphosphatidylcholine.
McLean LR; Buck SH; Krstenansky JL
Biochemistry; 1990 Feb; 29(8):2016-22. PubMed ID: 2158344
[TBL] [Abstract][Full Text] [Related]
6. Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction.
Chen H; Fetscher C; Schäfers RF; Wambach G; Philipp T; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):314-23. PubMed ID: 8692287
[TBL] [Abstract][Full Text] [Related]
7. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
Widdowson PS; Buckingham R; Williams G
Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
[TBL] [Abstract][Full Text] [Related]
9. [Leu31-Pro34] neuropeptide Y identifies a subtype of 125I-labeled peptide YY binding sites in the rat brain.
Gehlert DR; Gackenheimer SL; Schober DA
Neurochem Int; 1992 Jul; 21(1):45-67. PubMed ID: 1303142
[TBL] [Abstract][Full Text] [Related]
10. The effects of selective amino acid substitution upon neuropeptide Y antisecretory potency in rat jejunum mucosa.
Cox HM; Krstenansky JL
Peptides; 1991; 12(2):323-7. PubMed ID: 2067984
[TBL] [Abstract][Full Text] [Related]
11. Y1 and Y2 receptor selective neuropeptide Y analogues: evidence for a Y1 receptor subclass.
Kirby DA; Koerber SC; May JM; Hagaman C; Cullen MJ; Pelleymounter MA; Rivier JE
J Med Chem; 1995 Oct; 38(22):4579-86. PubMed ID: 7473586
[TBL] [Abstract][Full Text] [Related]
12. The functional investigation of a human adenocarcinoma cell line, stably transfected with the neuropeptide Y Y1 receptor.
Holliday ND; Cox HM
Br J Pharmacol; 1996 Sep; 119(2):321-9. PubMed ID: 8886416
[TBL] [Abstract][Full Text] [Related]
13. Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226.
Abounader R; Villemure JG; Hamel E
Br J Pharmacol; 1995 Oct; 116(4):2245-50. PubMed ID: 8564255
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the receptor response for the neuropeptide Y-evoked suppression of parasympathetically-mediated contractions in the guinea pig trachea.
Grundemar L
Regul Pept; 1997 Aug; 71(2):97-101. PubMed ID: 9416991
[TBL] [Abstract][Full Text] [Related]
15. Characterization of vascular neuropeptide Y receptors.
Grundemar L; Jonas SE; Mörner N; Högestätt ED; Wahlestedt C; Håkanson R
Br J Pharmacol; 1992 Jan; 105(1):45-50. PubMed ID: 1317737
[TBL] [Abstract][Full Text] [Related]
16. Activation of neuropeptide Y1 and neuropeptide Y2 receptors by substituted and truncated neuropeptide Y analogs: identification of signal epitopes.
Grundemar L; Krstenansky JL; Håkanson R
Eur J Pharmacol; 1993 Mar; 232(2-3):271-8. PubMed ID: 8467862
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
18. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.
Larsen PJ; Sheikh SP; Jakobsen CR; Schwartz TW; Mikkelsen JD
Eur J Neurosci; 1993 Dec; 5(12):1622-37. PubMed ID: 8124516
[TBL] [Abstract][Full Text] [Related]
19. Evidence for two neuropeptide Y receptors mediating vasoconstriction.
Modin A; Pernow J; Lundberg JM
Eur J Pharmacol; 1991 Oct; 203(2):165-71. PubMed ID: 1666044
[TBL] [Abstract][Full Text] [Related]
20. Differential vascular effects of neuropeptide Y(NPY) selective receptor agonists.
Evéquoz D; Grouzmann E; Beck-Sickinger AG; Brunner HR; Waeber B
Experientia; 1994 Oct; 50(10):936-8. PubMed ID: 7957768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
